Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

DE CRAIG RANCH, LLC

NPI: 1740724780 · LAS VEGAS, NV 89147 · General Acute Care Hospital · NPI assigned 12/09/2016

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official BUCK, JOHN controls 11+ related entities in our dataset. Read more

$1.62M
Total Medicaid Paid
80,773
Total Claims
71,364
Beneficiaries
57
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialBUCK, JOHN (PRESIDENT)
Parent OrganizationDE CRAIG RANCH, LLC
NPI Enumeration Date12/09/2016

Related Entities

Other providers sharing the same authorized official: BUCK, JOHN

ProviderCityStateTotal Paid
HCN EP HORIZON CITY, LLC HORIZON CITY TX $20.85M
DE CRAIG RANCH, LLC NORTH LAS VEGAS NV $13.97M
DE CRAIG RANCH, LLC LAS VEGAS NV $7.84M
IACC/EHI NW, LLC OKLAHOMA CITY OK $6.14M
IACC/EHI NW, LLC DEL CITY OK $6.01M
IACC/EHI NW, LLC OKLAHOMA CITY OK $4.30M
DE CRAIG RANCH, LLC LAS VEGAS NV $3.05M
EMP IDAHO NAMPA, LLC NAMPA ID $1.38M
IACC/EHI NW, LLC MOORE OK $757K
SCL HEALTH WESTMINSTER, LLC NORTHGLENN CO $25K
SCL HEALTH WESTMINSTER, LLC LITTLETON CO $1K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,149 $13K
2019 7,926 $152K
2020 8,646 $163K
2021 13,723 $284K
2022 18,252 $391K
2023 18,403 $370K
2024 12,674 $252K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 7,667 6,843 $353K
99284 Emergency department visit for the evaluation and management, high severity 4,284 3,807 $351K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,808 2,560 $322K
74177 Computed tomography, abdomen and pelvis; with contrast material 399 369 $93K
87428 2,349 2,208 $90K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,341 2,046 $50K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 682 641 $40K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,091 1,039 $36K
96375 Therapeutic injection; each additional sequential IV push 1,928 1,614 $33K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 4,860 4,002 $19K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,485 1,187 $16K
74176 Computed tomography, abdomen and pelvis; without contrast material 104 103 $16K
71045 Radiologic examination, chest; single view 1,629 1,514 $16K
70450 Computed tomography, head or brain; without contrast material 140 133 $14K
96361 Intravenous infusion, hydration; each additional hour 1,161 1,042 $11K
80053 Comprehensive metabolic panel 2,062 1,743 $10K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1,894 1,693 $10K
80051 2,724 2,384 $9K
82550 2,793 2,422 $9K
81025 2,411 2,211 $9K
71046 Radiologic examination, chest; 2 views 468 418 $8K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,119 1,058 $8K
84484 1,588 1,304 $8K
82977 2,014 1,831 $7K
82565 2,726 2,385 $7K
82150 2,040 1,855 $7K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 223 209 $6K
82947 2,956 2,459 $6K
84460 1,862 1,694 $5K
84520 2,727 2,385 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 842 383 $5K
84450 1,864 1,696 $5K
84075 1,862 1,694 $5K
82247 1,863 1,695 $4K
82040 1,862 1,694 $4K
81003 3,741 3,419 $4K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 169 154 $4K
84155 1,863 1,695 $3K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 101 95 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 101 95 $2K
83605 365 311 $2K
80305 286 273 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 129 114 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 661 577 $1K
87420 163 156 $1K
83880 69 65 $1K
87086 Culture, bacterial; quantitative colony count, urine 228 221 $925.35
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 256 245 $909.56
85379 147 142 $703.46
J2405 Injection, ondansetron hydrochloride, per 1 mg 656 583 $495.58
87400 50 25 $337.43
99281 Emergency department visit for the evaluation and management, self-limited or minor 15 13 $255.16
J1100 Injection, dexamethasone sodium phosphate, 1 mg 168 152 $126.34
96376 23 13 $120.67
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 702 654 $119.82
J2270 Injection, morphine sulfate, up to 10 mg 34 27 $70.16
J1200 Injection, diphenhydramine hcl, up to 50 mg 18 14 $20.22